Department of Neurosurgery, Regional Hospital Liberec, Liberec, Czech Republic.
Eur Spine J. 2010 Feb;19(2):307-15. doi: 10.1007/s00586-009-1259-3. Epub 2009 Dec 25.
Cervical total disc replacement (CTDR) aims to decrease the incidence of adjacent segment disease through motion preservation in the operated disc space. Ongoing data collection and increasing number of studies describing heterotopic ossification (HO) resulting in decreased mobility of implants, forced us to carefully evaluate our long-term clinical and morphological results of patients with CTDR. We present the first 54 consecutive patients treated with 65 ProdiscC prostheses during a 12-month period (2/2004-3/2005). All patients signed an informed consent and were included in prospective long-term study approved by hospital ethical committee. The 1- and 2-year follow-up analysis were available for all patients included and 4-year results for 50 patients (60 implants). Clinical (neck disability index-NDI, visual analog scale-VAS) and radiological follow-up was conducted at 1-, 2- and 4-years after the procedure. The Mehren/Suchomel modification of McAfee scale was used to classify the appearance of HO. Mean preoperative NDI was 34.5%, VAS for neck pain intensity 4.6 and VAS for arm pain intensity 5.0. At 1-, 2- and 4-year follow-up, the mean NDI was 30.7, 27.2, and 30.4, mean VAS for neck pain intensity 2.5, 2.1 and 2.9 and mean VAS for arm pain intensity pain 2.2, 1.9 and 2.3, respectively. Significant HO (grade III) was present in 45% of implants and segmental ankylosis (grade IV) in another 18% 4 years after intervention. This finding had no clinical consequences and 92% of patients would undergo the same surgery again. Our clinical results (NDI, VAS) are comparable with fusion techniques. Although, advanced non-fusion technology is used, a significant frequency of HO formation and spontaneous fusion in cervical disc replacement surgery must be anticipated during long-term follow-up.
颈椎全椎间盘置换术(CTDR)旨在通过保留手术节段的活动度来降低相邻节段疾病的发生率。由于植入物的异位骨化(HO)导致活动度降低的持续数据收集和越来越多的研究描述,迫使我们仔细评估 CTDR 患者的长期临床和形态学结果。我们介绍了在 12 个月期间(2004 年 2 月至 2005 年 3 月)使用 65 个 ProdiscC 假体治疗的前 54 例连续患者。所有患者均签署了知情同意书,并被纳入医院伦理委员会批准的前瞻性长期研究。所有纳入患者均进行了 1 年和 2 年的随访分析,50 例患者(60 个植入物)进行了 4 年的随访分析。术后 1、2 和 4 年分别进行临床(颈部残疾指数-NDI、视觉模拟评分-VAS)和影像学随访。采用 Mehren/Suchomel 改良的 McAfee 量表对 HO 的外观进行分类。术前 NDI 的平均分数为 34.5%,颈痛强度的 VAS 为 4.6,手臂痛强度的 VAS 为 5.0。在 1、2 和 4 年的随访中,NDI 的平均分数分别为 30.7、27.2 和 30.4,颈痛强度的 VAS 平均分数分别为 2.5、2.1 和 2.9,手臂痛强度的 VAS 平均分数分别为 2.2、1.9 和 2.3。在干预后 4 年,45%的植入物存在明显的 HO(III 级),另外 18%存在节段性强直(IV 级)。这一发现没有临床后果,92%的患者会再次接受同样的手术。我们的临床结果(NDI,VAS)与融合技术相当。尽管使用了先进的非融合技术,但在颈椎间盘置换术的长期随访中,必须预计到 HO 形成和自发性融合的发生率较高。